Rhumbline Advisers Age X Therapeutics, Inc. Transaction History

Rhumbline Advisers

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$0.68 - $1.13 $14,496 - $24,089	-21,318 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$1.25 - $1.82 $396 - $576	-317 Reduced 1.47%	21,318 $39,000
Q3 2019 Oct 23, 2019	SELL	$1.96 - $3.38 $392 - $676	-200 Reduced 0.92%	21,635 $42,000
Q2 2019 Aug 14, 2019	BUY	$2.58 - $4.92 $21,303 - $40,624	8,257 Added 60.81%	21,835 $80,000
Q1 2019 May 01, 2019	BUY	$3.0 - $4.85 $2,283 - $3,690	761 Added 5.94%	13,578 $55,000
Q4 2018 Jan 31, 2019	BUY	$2.49 - $5.5 $31,914 - $70,493	12,817 New	12,817 $38,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.